蝨子治療市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、藥物、配銷通路、地區和競爭格局分類，2021-2031年預測

全球蝨子治療市場規模將從2025年的11.4億美元成長到2031年的15.7億美元，年複合成長率為5.48%。該市場涵蓋外用殺蝨劑（如洗髮精和乳液）以及用於根除頭蝨感染的機械去除設備。市場成長的主要促進因素是學齡兒童頭蝨感染的持續流行以及非處方治療藥物的日益普及。

主要市場促進因素

學齡兒童頭蝨感染率的不斷攀升是蝨子治療市場持續成長的主要推動因素。這種疾病在教育和托幼機構中透過直接的頭部接觸迅速傳播，從而導致對有效根除方案的周期性需求。

主要市場挑戰

頭蝨對擬除蟲菊酯類製劑的生物抗藥性日益增強，這構成了全球蝨子治療市場成長的巨大障礙。這種生理適應性在一些被稱為「超級蝨子」的蝨株中表現得尤為明顯，使得許多標準的非處方殺蝨劑失效。

主要市場趨勢

由於蝨子對傳統擬除蟲菊酯類藥物的抗藥性日益嚴重，市場正經歷著向無毒且作用機制為物理作用的製劑的重大轉變。消費者和醫療保健提供者越來越傾向於使用含有多殺菌素或二甲矽油等成分的產品，這些成分利用機械或新型生物機制來根除蝨子，而不是依賴神經毒性化學物質。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球蝨子治療市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依類型（頭蝨病、體蝨病、陰蝨病）
  • 依藥品分類（非處方藥、處方藥）
  • 按配銷通路（醫院藥房、零售藥房、網路藥房）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美蝨子治療市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲蝨子治療市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區蝨子治療市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲蝨子治療市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲蝨子治療市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球蝨子治療市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Alliance Pharmaceuticals
• Omega Pharma
• Prestige Brands Holdings Inc.
• Johnson & Johnson
• Fleming Medical Ltd
• Oystershell Consumer Health, Inc
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

第16章：策略建議

第17章調查會社について,免責事項

The Global Lice Treatment Market will grow from USD 1.14 Billion in 2025 to USD 1.57 Billion by 2031 at a 5.48% CAGR. The Global Lice Treatment Market encompasses topical pediculicides, such as shampoos and lotions, alongside mechanical removal devices designed for the eradication of pediculosis infestations. The market's trajectory is fundamentally supported by the persistent prevalence of head lice among school-aged children and the expanding accessibility of over-the-counter therapeutic options.

Key Market Drivers

The escalating prevalence of pediculosis capitis among school-aged children serves as a primary catalyst for the sustained growth of the lice treatment market. This condition spreads rapidly in educational and childcare settings through direct head-to-head contact, creating a cyclical demand for effective eradication solutions. As classrooms and extracurricular activities facilitate transmission, the sheer volume of infestations necessitates frequent therapeutic interventions by parents and guardians.

Key Market Challenges

The escalating biological resistance of head lice to pyrethroid-based formulations constitutes a formidable barrier to the growth of the Global Lice Treatment Market. This physiological adaptation, observed in strains widely known as "super lice," renders many standard over-the-counter pediculicides ineffective. When these established chemical treatments fail to eradicate infestations, consumer confidence in conventional product lines diminishes significantly.

Key Market Trends

The market is witnessing a decisive transition toward non-toxic and physical mode-of-action formulations as a response to the widespread resistance of lice to traditional pyrethroid-based treatments. Consumers and healthcare providers are increasingly favoring products containing ingredients like spinosad or dimethicone, which utilize mechanical or novel biological mechanisms to eradicate infestations rather than relying on neurotoxic chemicals. This shift is driving significant revenue growth for pharmaceutical companies holding rights to these advanced therapies.

Key Market Players

• Alliance Pharmaceuticals
• Omega Pharma
• Prestige Brands Holdings Inc.
• Johnson & Johnson
• Fleming Medical Ltd
• Oystershell Consumer Health, Inc
• Nisarg Pharma
• ParaPRO Pharmaceuticals
• ICB Pharma
• Marico

Report Scope:

In this report, the Global Lice Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lice Treatment Market, By Type:

• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis

Lice Treatment Market, By Drugs:

• OTC Drugs
• Prescription Drugs

Lice Treatment Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Lice Treatment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lice Treatment Market.

Available Customizations:

Global Lice Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lice Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis)
  • 5.2.2. By Drugs (OTC Drugs, Prescription Drugs)
  • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Lice Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Drugs
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Lice Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Drugs
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Lice Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Drugs
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Lice Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Drugs
      • 6.3.3.2.3. By Distribution Channel

7. Europe Lice Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Drugs
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Lice Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Drugs
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Lice Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Drugs
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Lice Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Drugs
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Lice Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Drugs
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Lice Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Drugs
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Lice Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Drugs
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Lice Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Drugs
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Lice Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Drugs
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Lice Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Drugs
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Lice Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Drugs
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Lice Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Drugs
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Lice Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Drugs
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Lice Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Drugs
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Lice Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Drugs
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Lice Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Drugs
      • 9.3.3.2.3. By Distribution Channel

10. South America Lice Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Drugs
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Lice Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Drugs
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Lice Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Drugs
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Lice Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Drugs
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Lice Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Alliance Pharmaceuticals
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Omega Pharma
• 15.3. Prestige Brands Holdings Inc.
• 15.4. Johnson & Johnson
• 15.5. Fleming Medical Ltd
• 15.6. Oystershell Consumer Health, Inc
• 15.7. Nisarg Pharma
• 15.8. ParaPRO Pharmaceuticals
• 15.9. ICB Pharma
• 15.10. Marico

16. Strategic Recommendations

17. About Us & Disclaimer